{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T11:09:02Z","timestamp":1743160142193},"reference-count":29,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":5364,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1998,7]]},"abstract":"<jats:p>This study was conducted to determine whether loop diuretics are more effective than placebo in reducing blood pressure without raising serum lipid levels, and whether bumetanide is more effective than furosemide in this respect. In a double\u2010blind, 24\u2010week placebo\u2010controlled crossover study, 27 patients with essential hypertension were treated in four periods of 6 weeks each, including placebo twice, furosemide 40 mg daily, and bumetanide 1 mg daily. Several metabolic parameters, including serum lipid levels, and blood pressure were assessed. Overall levels of total cholesterol, triglycerides, and low\u2010density lipoprotein (LDL) cholesterol were 5%, 12.4%, and 4.8% higher, respectively, during loop diuretic therapy than during placebo treatment. Overall systolic and diastolic blood pressure measurements were 12 mmHg and 4 mmHg lower, respectively, during loop diuretic therapy than during placebo treatment. Any added effect of bumetanide on serum lipid levels and blood pressure compared with furosemide, however, could not be confirmed. Our results indicate that the loop diuretics bumetanide and furosemide are effective in reducing blood pressure, and influence serum lipid levels markedly less than do thiazide diuretics or chlorthalidone. In addition, these results indicate that differences in blood pressure reduction and serum lipid levels between the two compounds were small and nonsignificant.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1998.tb04470.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T18:17:45Z","timestamp":1362766665000},"page":"630-635","source":"Crossref","is-referenced-by-count":13,"title":["A Randomized, Placebo\u2010Controlled Study of Loop Diuretics in Patients with Essential Hypertension: The Bumetanide and Furosemide on Lipid Profile (BUFUL) Clinical Study Report"],"prefix":"10.1002","volume":"38","author":[{"given":"Marjon","family":"van der Heijden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Servaes H.","family":"Donders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ton J.","family":"Cleophas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menco G.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Bernink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben A.","family":"De Planque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst E.","family":"van der Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6488.97"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198710000-00009"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6824.405"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated hypertension","volume":"278","author":"Kostis JB, Davis BR, Cutler J, Grimm RH, Berge KG, Cohen JD, et al, for the SHEP Cooperative Reseach Group","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90956-2"},{"key":"e_1_2_1_7_2","first-page":"III\u2010120","article-title":"Effects of antihypertensive therapy on serum lipoproteins","volume":"5","author":"Weidman P","year":"1983","journal-title":"Hypertension"},{"issue":"4","key":"e_1_2_1_8_2","first-page":"325","article-title":"Increased ratio between beta\u2010 and alpha\u2010lipoproteins during diuretic therapy: an adverse effect","volume":"55","author":"Gluck Z","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90165-8"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-2-206"},{"key":"e_1_2_1_11_2","first-page":"137","article-title":"Metabolic effects of antihypertensive treatment with nifedipine or furosemide: a double\u2010blind, crossover study","volume":"9","author":"Lind L","year":"1995","journal-title":"J Hum Hypertens"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998309109846"},{"issue":"1","key":"e_1_2_1_13_2","first-page":"526","article-title":"Effects of diuretics on serum lipoproteins","volume":"6","author":"Weidmann P","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90518-7"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198632030-00003"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90631-5"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/13.suppl_G.61"},{"key":"e_1_2_1_18_2","first-page":"625","article-title":"Der einfluss von Diuretika auf die Serumlipoproteine","volume":"110","author":"Sonnichsen AC","year":"1992","journal-title":"Fortschr Med"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-2-199501150-00010"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331977702800209"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01870937"},{"key":"e_1_2_1_22_2","first-page":"35","article-title":"Changing Burinex K (bumetanide + potassium) to furosemide\/amiloride treatment increases cholesterol and decreases HDL\u2010cholesterol","volume":"50","author":"Daensvang PA","year":"1991","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_23_2","volume-title":"Pilot study Nm 25397","author":"Barth JD","year":"1997"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archinte.1993.00410020010002","article-title":"The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC V)","volume":"153","author":"Joint National Committee","year":"1993","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","DOI":"10.4324\/9780203009277","volume-title":"Design and Analysis of Crossover Trials.","author":"Jones B","year":"1989"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90944-Z"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05381-6"},{"key":"e_1_2_1_28_2","first-page":"159","volume-title":"Human Pharmacology.","author":"Fink GD","year":"1994"},{"key":"e_1_2_1_29_2","first-page":"781","volume-title":"Goodman & Gilman's Pharmacological Basis of Therapeutics.","author":"Oates JA","year":"1996"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1996.tb00188.x"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1998.tb04470.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1998.tb04470.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T11:52:21Z","timestamp":1698493941000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1998.tb04470.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1002\/j.1552-4604.1998.tb04470.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1998.tb04470.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}